止血製品の世界市場

止血製品の世界市場は2030年までに179億米ドルに達する見込み

2023年に138億米ドルと推定される止血製品の世界市場は、2023年から2030年にかけてCAGR 3.8%で成長し、2030年には179億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである輸液止血製品は、CAGR 3.4％を記録し、分析期間終了時には86億米ドルに達すると予測されます。トピカル止血製品分野の成長率は、分析期間中CAGR 3.9％と推定されます。

米国市場は37億米ドルと推定、中国はCAGR6.2％で成長予測

米国の止血製品市場は2023年に37億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR 6.2％を引きずる形で、2030年までに予測市場規模36億米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.0％と3.1％と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界の止血製品市場- 主要動向と促進要因のまとめ

止血製品は外科手術や外傷治療にどのように不可欠か？

止血製品は、手術や外傷時の出血をコントロールし、患者の安全を確保し、合併症を最小限に抑えるために不可欠です。外用剤、シーラント、止血ドレッシング材を含むこれらの製品は、外科医がより安全に手技を行えるよう、即座に出血をコントロールします。緊急外傷治療において、止血製品は過剰な出血を防ぎ、重篤な症例の生存率を向上させるために不可欠です。外科手術や外傷症例が世界中で増加するにつれ、信頼性が高く効果的な止血ソリューションへの需要が高まっています。

なぜ高度止血ソリューションの需要が増加しているのか？

ヘルスケアプロバイダーがより迅速で効果的な出血コントロールを提供する製品を求めているため、高度止血ソリューションの需要は増加傾向にあります。フィブリンシーラント、コラーゲンベースのドレッシング材、遺伝子組換えトロンビンなどの技術革新により、凝固能力が強化され、手術時間が短縮され、患者の転帰が改善されます。また、低侵襲手術には正確な適用を伴う止血製品が必要とされ、高度なソリューションへの需要を牽引しています。ヘルスケアシステムが効率性と患者の安全性を優先するにつれ、先進的な止血製品は最新の外科医療に不可欠なものとなってきています。

ヘモスタシス製品の採用における規制認可の役割とは？

止血製品市場では、重要な出血コントロールに使用される製品の安全性と有効性が最も重要であるため、薬事承認が極めて重要です。FDAやEMAのような規制機関は、止血製品が厳格な臨床試験を必要とする厳しい品質基準を満たしていることを保証します。承認された製品はより信頼され、ヘルスケア現場でより広く採用されるため、規制遵守は市場成功の重要な要因となっています。ヘルスケア施設では安全で効果的な製品が優先されるため、患者ケアの品質基準を維持するためには、規制当局の承認を受けた止血ソリューションが不可欠です。

止血製品市場の成長の原動力は？

止血製品市場の成長の原動力は、外科手術の増加、高度な止血ソリューションの需要、厳格な規制基準です。手術件数の増加や外傷症例の増加が、ヘルスケア現場における効果的な止血製品の需要に拍車をかけています。即効性のあるシーラントや強化された凝固剤など、製品設計の進歩は患者の転帰を向上させ、手術室に不可欠なものとなっています。さらに、製品の安全性と有効性に関する規制要件が市場の成長をさらに後押しし、止血製品は重要かつ日常的な外科治療に不可欠なツールとなっています。

セグメント

製品（浸潤性止血剤、局所止血剤、高度止血剤）、用途（血友病、外傷、外科手術、心筋梗塞、脳卒中、血栓症）

調査対象企業の例（全46件）

• Abbott Laboratories, Inc.
• BARD, A Becton, Dickinson Company
• Baxter International, Inc.
• CSL Behring
• Grifols SA
• Integra Life Sciences Corporation
• Johnson & Johnson
• Medtronic PLC
• Pfizer, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Hemostasis Products Market to Reach US$17.9 Billion by 2030

The global market for Hemostasis Products estimated at US$13.8 Billion in the year 2023, is expected to reach US$17.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Infusible Hemostasis Products, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Topical Hemostasis Products segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 6.2% CAGR

The Hemostasis Products market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Hemostasis Products Market - Key Trends & Drivers Summarized

How Are Hemostasis Products Essential in Surgical and Trauma Care?

Hemostasis products are vital in controlling bleeding during surgeries and trauma situations, ensuring patient safety and minimizing complications. These products, which include topical agents, sealants, and hemostatic dressings, provide immediate bleeding control, allowing surgeons to perform procedures more safely. In emergency trauma care, hemostasis products are essential for preventing excessive blood loss, improving survival rates in critical cases. As surgical procedures and trauma cases increase worldwide, demand for reliable and effective hemostasis solutions is growing.

Why Is Demand for Advanced Hemostasis Solutions Increasing?

Demand for advanced hemostasis solutions is on the rise, as healthcare providers seek products that offer faster and more effective bleeding control. Innovations such as fibrin sealants, collagen-based dressings, and recombinant thrombin provide enhanced clotting capabilities, reducing surgical time and improving patient outcomes. Minimally invasive surgeries also require hemostasis products with precise application, driving demand for advanced solutions. As healthcare systems prioritize efficiency and patient safety, advanced hemostasis products are becoming essential in modern surgical care.

What Role Does Regulatory Approval Play in Hemostasis Product Adoption?

Regulatory approval is crucial in the hemostasis products market, as safety and efficacy are paramount for products used in critical bleeding control. Regulatory agencies such as the FDA and EMA ensure that hemostasis products meet stringent quality standards, requiring rigorous clinical testing. Approved products gain greater trust and are more widely adopted in healthcare settings, making regulatory compliance a key factor in market success. With healthcare facilities prioritizing safe and effective products, regulatory-approved hemostasis solutions are essential for maintaining quality standards in patient care.

What Drives the Growth of the Hemostasis Products Market?

The growth in the hemostasis products market is driven by increasing surgical procedures, demand for advanced bleeding control solutions, and strict regulatory standards. Rising surgical volumes and trauma cases are fueling demand for effective hemostasis products in healthcare settings. Advances in product design, such as fast-acting sealants and enhanced clotting agents, support better patient outcomes, making them indispensable in operating rooms. Additionally, regulatory requirements for product safety and efficacy further support market growth, positioning hemostasis products as essential tools in critical and routine surgical care.

SCOPE OF STUDY:

The report analyzes the Hemostasis Products market in terms of US$ Million by the following Application; Product, and Geographic Regions/Countries:

Segments:

Product (Infusible Hemostasis, Topical Hemostasis, Advanced Hemostasis); Application (Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke, Thrombosis)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

• Abbott Laboratories, Inc.
• BARD, A Becton, Dickinson Company
• Baxter International, Inc.
• CSL Behring
• Grifols SA
• Integra Life Sciences Corporation
• Johnson & Johnson
• Medtronic PLC
• Pfizer, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Hemostasis Products - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Effective Bleeding Control Solutions in Trauma Care
  • Growth in Hemostatic Agents and Dressings for Surgical Use
  • Increasing Adoption of Topical Hemostats in Outpatient Settings
  • Expansion of Hemostasis Products in Dental and Orthopedic Procedures
  • Higher Demand for Advanced Wound Care Products in Hemostasis
  • Development of Biocompatible and Fast-Acting Hemostatic Products
  • Increased Use of Hemostatic Dressings in Military and Emergency Care
  • Growth in Demand for Hemostasis Products in Oncology and Critical Care
  • Expansion of Hemostatic Agents in Minimally Invasive Surgeries
  • Growth of E-commerce Platforms Offering Hemostatic Products
  • Rising Adoption of Hemostasis Products in Sports Medicine
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Hemostasis Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Hemostasis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Infusible Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Infusible Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Infusible Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Topical Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Topical Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Topical Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Advanced Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Advanced Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Advanced Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hemophilia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hemophilia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hemophilia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Myocardial Infarction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Myocardial Infarction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Myocardial Infarction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: World 16-Year Perspective for Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• JAPAN
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• CHINA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 50: China Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: China 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 53: China Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: China 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• EUROPE
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Hemostasis Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• FRANCE
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 65: France Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: France 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 68: France Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: France Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: France 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• GERMANY
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 74: Germany Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Germany Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Germany 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 80: Italy Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Italy Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Italy 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 83: UK Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 86: UK Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: UK Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: UK 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 89: Spain Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Spain Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Spain 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 92: Spain Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Spain Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Spain 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 95: Russia Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Russia Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Russia 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 98: Russia Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Russia Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Russia 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Rest of Europe Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Rest of Europe 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Rest of Europe Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Rest of Europe 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Hemostasis Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Asia-Pacific 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Asia-Pacific Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: Asia-Pacific 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Asia-Pacific Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: Asia-Pacific 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 116: Australia Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: Australia Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: Australia 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 119: Australia Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Australia Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: Australia 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• INDIA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 122: India Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: India Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: India 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 125: India Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 126: India Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 127: India 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 129: South Korea Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 130: South Korea 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 131: South Korea Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 132: South Korea Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 133: South Korea 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Rest of Asia-Pacific Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Rest of Asia-Pacific Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 141: Latin America Historic Review for Hemostasis Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 142: Latin America 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Latin America Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 145: Latin America 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 146: Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Latin America Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 148: Latin America 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Argentina Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 151: Argentina 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 152: Argentina Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Argentina Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 154: Argentina 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Brazil Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 157: Brazil 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 158: Brazil Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Brazil Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 160: Brazil 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Mexico Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 163: Mexico 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 164: Mexico Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Mexico Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 166: Mexico 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Rest of Latin America Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 169: Rest of Latin America 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Rest of Latin America Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 172: Rest of Latin America 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 174: Middle East Historic Review for Hemostasis Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 175: Middle East 16-Year Perspective for Hemostasis Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 177: Middle East Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 178: Middle East 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 179: Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Middle East Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 181: Middle East 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 182: Iran Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Iran Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 184: Iran 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 185: Iran Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Iran Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 187: Iran 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 188: Israel Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Israel Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 190: Israel 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 191: Israel Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Israel Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 193: Israel 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Saudi Arabia Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 196: Saudi Arabia 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Saudi Arabia Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 199: Saudi Arabia 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 200: UAE Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 201: UAE Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 202: UAE 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 203: UAE Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 204: UAE Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 205: UAE 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Rest of Middle East Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 208: Rest of Middle East 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 210: Rest of Middle East Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 211: Rest of Middle East 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030
• AFRICA
  • Hemostasis Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 212: Africa Recent Past, Current & Future Analysis for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 213: Africa Historic Review for Hemostasis Products by Product - Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 214: Africa 16-Year Perspective for Hemostasis Products by Product - Percentage Breakdown of Value Sales for Infusible Hemostasis, Topical Hemostasis and Advanced Hemostasis for the Years 2014, 2024 & 2030
  • TABLE 215: Africa Recent Past, Current & Future Analysis for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 216: Africa Historic Review for Hemostasis Products by Application - Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 217: Africa 16-Year Perspective for Hemostasis Products by Application - Percentage Breakdown of Value Sales for Hemophilia, Trauma, Surgery, Myocardial Infarction, Stroke and Thrombosis for the Years 2014, 2024 & 2030

IV. COMPETITION